Xttrium Laboratories, Inc. – FDA 483, Jun 18, 2025
Xtrium Laboratories, Inc., an API and Finished Product Drug Manufacturer in Mount Prospect, IL, was cited for significant deficiencies across its quality control, data integrity, and record-keeping practices. The inspection revealed issues with unqualified equipment, undocumented analyses, inadequate computer system controls, and a failure to investigate discrepancies, all of which compromise the reliability and integrity of their analytical data and product quality. These findings indicate a systemic breakdown in adherence to established procedures and regulatory requirements.
ID · c29d29eb-46f3-4104-a21c-2f5a99530b5a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.